XTRA:AFXMedical Equipment
A Look At Carl Zeiss Meditec (XTRA:AFX) Valuation After CEO Change And Lower Revenue Guidance
Carl Zeiss Meditec (XTRA:AFX) has drawn fresh investor attention after appointing Bronwyn Brophy O’Connor as CEO, just weeks after reporting lower quarterly earnings and setting revenue guidance below the prior year.
See our latest analysis for Carl Zeiss Meditec.
The leadership change and softer revenue guidance come after a sharp reset in expectations, with the share price down 33.7% year to date and the 1 year total shareholder return falling 53.2%, while the recent 7 day share price...